News

Researchers have identified a possible reason why some aggressive breast cancers are unresponsive to certain immunotherapy treatments, as well as a potential solution.

New mechanism of stomach gland regeneration reveals impact of Helicobacter pylori infection.

Cambridge Epigenetix and NuGEN Technologies come together to integrate the oxidative bisulfite sequencing (oxBS-Seq) with NGS library preparation kits.

A team at the MD Anderson Cancer center team has found that checkpoint inhibitors fire up different types of T cells to attack tumors

A recent Nature Medicine paper outlines the role of mutations within the SPOP gene on the development of resistance to one class of drugs.

A Yale-led team of researchers has identified specific gene combinations that can cause the deadly brain cancer glioblastoma, using new technology that can also pinpoint triggers of other types cancers.

The system works by predicting the co-occurrence of about 500 known tumour alterations, as well as their response to over 200 common cancer drugs.

Early phase Northwestern Medicine research published in PNAS has demonstrated a potential new therapeutic strategy for treating deadly glioblastoma brain tumors.

New hybrid shows promise in dealing a double blow to cancer cells by delivering both a chemotherapeutic agent and RNAi technology that silences drug resistance.

Researchers are hoping this icon of artificial intelligence will help people with cancer win as well by providing a rapid, comprehensive report of the genetic mutations at the root of their specific disease and the therapies that target them.